FdaApplication
ANDA 215675
Identifiers
- fda_app_no: ANDA215675
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2022-09-14 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PREGABALIN | PREGABALIN | 82.5MG | TABLET, EXTENDED RELEASE;ORAL |
| PREGABALIN | PREGABALIN | 330MG | TABLET, EXTENDED RELEASE;ORAL |
| PREGABALIN | PREGABALIN | 165MG | TABLET, EXTENDED RELEASE;ORAL |
3 products